BiotechTube
Home/LinkGevity/Rafal Libera
RL

Rafal Libera

Chief Growth Officer

LinkGevity

Therapeutic Areas

AgingKidney DiseaseInflammatory Bowel DiseaseOncology

LinkGevity Pipeline

DrugIndicationPhase
LINK-001Kidney Disease (Acute Kidney Injury)Phase 2
LINKAgingPhase 2
Anti-Necrotics PlatformVarious (Tissue Engineering, Organ Preservation)Non-Clinical

Leadership Team at LinkGevity

DC
Dr. Carina Kern
Chief Executive Officer
SK
Serena Kern-Libera
Chief Operating Officer
GJ
Greg Jarzabek
Chief Financial Officer
LR
Lukasz Rzeczkowski
Chief Commercial Officer
NG
Nikodem Grzesiak
Chief Technology Officer
BD
Bill Davis
Chief R&D Officer
View full LinkGevity profile